Qibin Liao
Overview
Explore the profile of Qibin Liao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Bai S, Cui Y, Liao Q, Yi H, Liao Z, Zhang G, et al.
Viruses
. 2025 Jan;
17(1).
PMID: 39861905
The re-emergence of the mpox pandemic poses considerable challenges to human health and societal development. There is an urgent need for effective prevention and treatment strategies against the mpox virus...
3.
Xue Y, Mao Y, Liao Q, Zhao C, Zhang X, Xu J
J Vis Exp
. 2024 Jul;
(208).
PMID: 38949315
Extensive studies have proven the promise of chimeric antigen receptor T (CAR-T) cell therapy in treating hematological malignancies. However, treating solid tumors remains challenging, as exemplified by the safety concerns...
4.
Mao Y, Liao Q, Zhu Y, Bi M, Zou J, Zheng N, et al.
Cell Discov
. 2024 May;
10(1):49.
PMID: 38740803
Chimeric antigen receptor T (CAR-T) cells have been proposed for HIV-1 treatment but have not yet demonstrated desirable therapeutic efficacy. Here, we report newly developed anti-HIV-1 CAR-T cells armed with...
5.
Guan Y, Qi T, Liao Q, Zhang R, Chen J, Liu L, et al.
AIDS Res Ther
. 2023 Feb;
20(1):11.
PMID: 36782323
Background: Men who have sex with men (MSM) is a key population for preventing HIV in China, yet pre-exposure prophylaxis (PrEP) is not widely accepted in this population. The objective...
6.
Liao X, Guan Y, Liao Q, Ma Z, Zhang L, Dong J, et al.
Glob Health Med
. 2023 Jan;
4(6):322-326.
PMID: 36589219
Although Omicron appears to cause less severe acute illness than the original strain, the potential for large numbers of patients to experience long COVID is a major concern. Little is...
7.
Gao B, Li C, Liao Q, Pan T, Ren C, Cao Q
Eur J Med Res
. 2022 Dec;
27(1):308.
PMID: 36572947
Purpose: To retrospectively investigate the epicardial fat volume with multidetector computed tomography (MDCT) and other risk factors for the prevalence of three-vessel coronary lesion. Materials And Methods: MDCT was performed...
8.
Liao Q, Liu Z, Zhu C, He H, Feng M, Jiang L, et al.
J Adv Res
. 2022 Aug;
47:163-171.
PMID: 35995414
Introduction: The on-target off-tumor toxicity of chimeric antigen receptor-engineered T cells (CAR-T) might lead to fatal side effects in cancer patients, which remains as a major obstacle to the clinical...
9.
Wang J, Zhang R, Ding X, Jin Y, Qin R, Xia B, et al.
Immunotherapy
. 2022 Apr;
14(8):599-607.
PMID: 35443802
Although there is a high curability rate with rituximab chemotherapy, approximately 40% of patients with diffuse large B-cell lymphoma (DLBCL) develop disease relapse or primary-refractory lymphoma. The prognosis of HIV+...
10.
He H, Liao Q, Zhao C, Zhu C, Feng M, Liu Z, et al.
J Immunother Cancer
. 2021 Oct;
9(10).
PMID: 34615704
Background: Hypoxia is a striking feature of most solid tumors and could be used to discriminate tumors from normoxic tissues. Therefore, the design of hypoxia-conditioned Chimeric Antigen Receptor (CAR) T...